Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Clinical Trial Comparing Treatment With Cangrelor (in Combination With Usual Care) to Usual Care, in Subjects Who Require Percutaneous Coronary Intervention (PCI)

Next Previous
X
Search
Trial Profile

A Clinical Trial Comparing Treatment With Cangrelor (in Combination With Usual Care) to Usual Care, in Subjects Who Require Percutaneous Coronary Intervention (PCI)

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cangrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes; Coronary disorders
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Acronyms CHAMPION-PLATFORM
  • Sponsors The Medicines Company

    • Most Recent Events

    • 17 Jan 2017 Results of a subgroup analysis of CHAMPION PCI, CHAMPION PLATFORM and CHAMPION PHOENIX trials (n=24,902) in patients who did not receive Glycoprotein IIb/IIIa Inhibitors, presented in the Journal of the American College of Cardiology
    • 24 Aug 2015 According to The Medicines Company media release, data from this study will be presented at the 2015 European Society of Cardiology (ESC) Congress.
    • 14 Nov 2014 The Medicines Company plans to resubmit an NDA for cangrelor by the end of 2014 with respect to the PCI indication, according to a media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top